Intuitive Surgical slides 13% as earnings hit by pre-tax charge
Intuitive Surgical (ISRG) reported Q3 earnings of $3.00 per share, beating estimates by $0.35, with revenue up 22% YoY to $3.05B. Shares fell 13.2% due to a $450M pre-tax charge. The company guided full-year procedure growth and margins, with strong performance across its platforms. Da Vinci system placements and procedures grew 14% and 15%, respectively.
How this was made
The 30-second read
Why it matters
The settlement charge created immediate negative sentiment, but underlying growth metrics remain strong, suggesting a potential rebound.
Market read
Earnings surprise offset by a large legal charge, driving a sharp share decline; traders may consider short positions or wait for price stabilization.
What to watch
Guidance on margin expansion and procedure volume growth may offset the charge over the longer term.
Background
Intuitive Surgical is a leading maker of da Vinci robotic surgery systems. The quarter featured record procedure volumes and a $450M antitrust settlement charge.
Ticker impact
Intuitive Surgical reported a $450M pre‑tax charge from an antitrust settlement, causing a 13.2% share drop despite earnings beat.
likely pressure as the market prices in the large settlement charge
The unexpected $450M charge is material and directly drove the stock lower, outweighing the EPS beat.
Market effects
Health‑care robotics may see short‑term valuation pressure as investors reassess litigation risk.
U.S. markets may see a modest pull on tech‑heavy indices due to ISRG weight.
Limited to investors tracking medical‑device stocks and broader tech exposure.
Counterpoint
The earnings beat and strong procedural growth could support a bounce if the settlement is viewed as a one‑off.
Key entities
- companyIntuitive Surgical Inc.
Robotic surgery equipment manufacturer (ticker ISRG).
- executiveDave Rosa
CEO of Intuitive Surgical who commented on the quarter's performance.

